Literature DB >> 30454753

Lupus Nephritis.

Scott E Wenderfer1, Karen W Eldin2.   

Abstract

Childhood-onset systemic lupus erythematosus (SLE) is a subset of SLE with an onset before 18 years of age. Patients with early onset SLE tend to have a greater genetic component to their disease cause, more multisystemic involvement, and a more severe disease course, which includes greater risks for developing nephritis and end-stage kidney disease. Five- and 10-year mortality is lower than in adult-onset SLE. Although patient and renal survival have improved with advances in induction and maintenance immunosuppression, accumulation of irreversible damage is common. Cardiovascular and infectious complications are frequent, as are relapses during adolescence and the transition to adulthood.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoantibody; Biopsy; Complement; Glomerulopathy; Hematuria; Lupus; Nephritis; Proteinuria

Mesh:

Substances:

Year:  2019        PMID: 30454753     DOI: 10.1016/j.pcl.2018.08.007

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  3 in total

1.  Serum amyloid A-to-albumin ratio as a potential biomarker to predict the activity, severity, and poor prognosis of systemic lupus erythematosus.

Authors:  Liang Zhao; Qun Zhang; Zhigang Feng; Jinshan Zhang; Feng He
Journal:  J Clin Lab Anal       Date:  2022-02-10       Impact factor: 2.352

2.  MALT1 serves as a biomarker for estimating disease risk of lupus nephritis: a prospective case-control study.

Authors:  Min Wang; Li Huang; Liping Peng; Yameng Yang; Jing Mao; Ning Zhu; Bin Wu
Journal:  Ann Transl Med       Date:  2022-08

3.  Clinical relevance of glomerular IgM deposition in patients with lupus nephritis.

Authors:  Fengmei Wang; Jirong Yu; Lei Zhang; Yan Zhang; Jie Zhang; Bicheng Liu; Xiaowei Yang
Journal:  BMC Immunol       Date:  2021-12-07       Impact factor: 3.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.